Ivan Bièche et al.
HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast
Journal of Hematology & Oncology 2021, vol. 14, issue 1
doi: 10.1186/s13045-021-01158-3
![Logo France Génomique](https://www.france-genomique.org/wp-content/uploads/2019/03/logo-FG-blue-RVB-medium.png)
Ivan Bièche et al.
HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast
Journal of Hematology & Oncology 2021, vol. 14, issue 1
doi: 10.1186/s13045-021-01158-3